Dengvaxia pregnancy registry in the US
Part of Infections clinical trials.
This registry collects information about people who were pregnant and exposed to the Dengvaxia vaccine during pregnancy, to better understand outcomes after that exposure. It may help future mothers and clinicians by building a clearer safety and health record over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant (or were pregnant) and your pregnancy is in the United States or its territories
- You (the pregnant person) received Dengvaxia exposure during pregnancy
- Your exposure can be documented well enough to confirm it happened during pregnancy
- The vaccine name is included in the report (brand or generic, even if the manufacturer is unknown)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
This study looks at how the dengue vaccine works in people with and without past exposure to dengue or similar viruses like yellow fever or Zika. Volunteers receiving the dengue vaccine will give blood samples to help researchers understand the immune response.
This is an observational registry that collects information about pregnant people and their babies when MenQuadfi® (a meningitis vaccine) was given during pregnancy or shortly before pregnancy. It helps researchers understand what happens to women and offspring after this vaccine exposure.
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.
This study tests a controlled dengue infection in people who already have immunity to some types of dengue. It aims to understand how the immune system responds and to help develop better vaccines. You may qualify if you are a healthy adult aged 18-40 and have evidence of prior dengue exposure to certain virus types.
Hear when a new Dengue Virus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.